Arguably a better indicator of pre-existing clinical thyroid disease, over 20% of patients were receiving thyroid hormone replacement (levothyroxine) prior to immunotherapy, with slightly more than half of these individuals having a normal TSH at time of ICI initiation. Here, TG is linked to thyroid gland disorder.